These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunosuppression in the treatment of insulin-dependent (type 1) diabetes. Rubenstein AH; Pyke D Lancet; 1987 Feb; 1(8530):436-7. PubMed ID: 2880226 [No Abstract] [Full Text] [Related]
6. [(Auto)immunological aspects of type 1 diabetes mellitus]. Dieterle C MMW Fortschr Med; 2006 Apr; 148(16):36-9; quiz 40. PubMed ID: 16688947 [TBL] [Abstract][Full Text] [Related]
7. Autoimmunity to islet cells in diabetes mellitus. Powers AC; Eisenbarth GS Annu Rev Med; 1985; 36():533-44. PubMed ID: 3888064 [TBL] [Abstract][Full Text] [Related]
8. [Immunosuppression in juvenile diabetes mellitus? Critical viewpoint on the treatment with cyclosporin A with consideration of the differential etiology]. Teuber J; Usadel KH Fortschr Med; 1985 Jul; 103(27-28):707-13. PubMed ID: 4029865 [No Abstract] [Full Text] [Related]
9. Immunosuppressive therapy in newly diagnosed diabetic children (comparison between two different strategies). Pocecco M; Marinoni S; Tonini G; Tedesco F J Endocrinol Invest; 1989; 12(8 Suppl 3):143-4. PubMed ID: 2809092 [No Abstract] [Full Text] [Related]
10. Type 1 diabetes mellitus. Larger E; Dubois-Laforgue D Ann Med Interne (Paris); 1999 Apr; 150(3):254-63. PubMed ID: 10445097 [No Abstract] [Full Text] [Related]
11. Prediction and prevention strategies in type I diabetes. Eisenbarth G Mt Sinai J Med; 1991 Sep; 58(4):274-9. PubMed ID: 1944312 [No Abstract] [Full Text] [Related]
12. Combined antibody screening for improved prediction of IDDM--modern strategies. Roll U; Ziegler AG Exp Clin Endocrinol Diabetes; 1997; 105(1):1-14. PubMed ID: 9088889 [No Abstract] [Full Text] [Related]
13. [Should screening for type 1 diabetes be encouraged in brothers and sisters of diabetic children?]. Lévy-Marchal C Diabete Metab; 1992; 18(1):65-8. PubMed ID: 1563541 [No Abstract] [Full Text] [Related]
14. [The autoimmune aspects of insulin-dependent diabetes mellitus. Immunocorrection trials in the early stages of the disease]. Efimov AS; Poltorak VV Probl Endokrinol (Mosk); 1989; 35(5):85-90. PubMed ID: 2511571 [No Abstract] [Full Text] [Related]
15. Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis. Redondo MJ; Oram RA; Steck AK Curr Diab Rep; 2017 Oct; 17(12):129. PubMed ID: 29080981 [TBL] [Abstract][Full Text] [Related]
16. [Atypical type 1 diabetes. The Danish Society for Child and Adolescent Diabetes]. Pörksen S; Olsen BS; Mortensen HB; Ugeskr Laeger; 2008 Mar; 170(12):1017. PubMed ID: 18397635 [No Abstract] [Full Text] [Related]
17. Type 1 diabetes: molecular, cellular and clinical immunology. Eisenbarth GS Adv Exp Med Biol; 2004; 552():306-10. PubMed ID: 15622970 [No Abstract] [Full Text] [Related]
18. [Latent type 1 diabetes (LADA diabetes). Diagnosis and management]. Thivolet C Journ Annu Diabetol Hotel Dieu; 2001; ():145-9. PubMed ID: 11565456 [No Abstract] [Full Text] [Related]
19. Predicting type I diabetes. Ziegler AG; Herskowitz RD; Jackson RA; Soeldner JS; Eisenbarth GS Diabetes Care; 1990 Jul; 13(7):762-5. PubMed ID: 2201499 [TBL] [Abstract][Full Text] [Related]
20. [Predisposition, early stages and phenotypes of type 1 diabetes]. Achenbach P; Winkler C; Haupt F; Beyerlein A; Ziegler AG Dtsch Med Wochenschr; 2014 May; 139(21):1100-4. PubMed ID: 24823976 [No Abstract] [Full Text] [Related] [Next] [New Search]